Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: One-year outcomes of the multicentre "cE-approval cohort"

EuroIntervention

Volumn 13, Issue 9, 2017, Pages e1040-e1046

  Möllmann, Helge ^a,b   Walther, Thomas ^a   Siqueira, Dimytri ^c   Diemert, Patrick ^d,e   Treede, Hendrik ^d,f   Grube, Eberhard ^g   Nickenig, Georg ^g   Baldus, Stephan ^h   Rudolph, Tanja ^h   Kuratani, Toru ⁱ   Sawal, Yoshiki ⁱ   Kempfert, Joerg ^a,j   Kim, Won Keun ^a   Abizaid, Alexandre ^c,k  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d UNIVERSITY HEART CENTER HAMBURG   (Germany)

^e Medizinische Klinik   (Germany)

^f MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^k HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

more..

Author keywords

Aortic stenosis; Death; Femoral; Stroke; Transcatheter aortic valve implantation

Indexed keywords

AGED; ALL CAUSE MORTALITY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COHORT ANALYSIS; ECHOCARDIOGRAPHY; EUROSCORE; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PATIENT SAFETY; PERFORMANCE; PROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR ACCESS; VERY ELDERLY; AORTIC VALVE; AORTIC VALVE STENOSIS; BRAZIL; CLINICAL TRIAL; DEVICES; EPIDEMIOLOGY; FOLLOW UP; GERMANY; HEART VALVE PROSTHESIS; MORTALITY; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BRAZIL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART VALVE PROSTHESIS; HUMANS; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85032457374     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJ-D-17-00187     Document Type: Article

References (28)

1. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a selfexpanding prosthesis. N Engl J Med. 2014;370:1790-8.
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators.Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
3. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477-84.
4. Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S, Mohr FW, Walther T. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52-6.
5. Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schröfel H, Thielmann M, Walther T. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48:137-41.
6. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACURATE TF™ aortic bioprosthesis.EuroIntervention. 2013;9 Suppl:S107-10.
7. Schäfer U, Conradi L, Diemert P, Deuschl F, Schofer N, Seiffert M, Lubos E, Schirmer J, Reichenspurner H, Blankenberg S, Treede H. Symetis ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve. Minerva Cardioangiol. 2015;63:359-69.
8. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-17.
9. Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, Meredith IT. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. JACC Cardiovasc Interv. 2015;8:1359-67.
10. Piazza N, Martucci G, Lachapelle K, de Varennes B, Bilodeau L, Buithieu J, Mylotte D. First-in-human experience with the Medtronic CoreValve Evolut R. EuroIntervention. 2014;9: 1260-3.
11. Treede H, Tubler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling SF, Meinertz T, Schofer J.Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg. 2010;140:897-903.
12. Meredith IT, Worthley SG, Whitbourn RJ, Antonis P, Montarello JK, Newcomb AE, Lockwood S, Haratani N, Allocco DJ, Dawkins KD. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9:1264-70.
13. Manoharan G, Spence MS, Rodés-Cabau J, Webb JG. St Jude Medical Portico valve. EuroIntervention. 2012;8 Suppl Q:Q97-101.
14. Willson AB, Rodés-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S, Binder RK, Freeman M, DeLarochellière R, Moss R, Nombela-Franco L, Dumont E, Szummer K, Fontana GP, Makkar R, Webb JG. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol. 2012;60:581-6.
15. Webb J, Gerosa G, Lefèvre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235-43.
16. Naber CK, Pyxaras SA, Ince H, Latib A, Frambach P, den Heijer P, Wagner D, Butter C, Colombo A, Kische S. Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis.EuroIntervention. 2016;11:e1314-20.
17. Meredith Am IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, Blackman DJ, Rioufol G, Hildick- Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Allocco DJ, Dawkins KD. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64:1339-48.
18. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB.Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3, 519 patients from 16 studies. J Am Coll Cardiol.2012;59:2317-26.
19. Schofer J, Nietlispach F, Bijuklic K, Colombo A, Gatto F, De Marco F, Mangieri A, Hansen L, Bruschi G, Ruparelia N, Rieß FC, Maisano F, Latib A. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation. JACC Cardiovasc Interv.2015;8:1842-9.
20. Herrmann HC, Thourani VH, Kodali SK, Makkar RR, Szeto WY, Anwaruddin S, Desai N, Lim S, Malaisrie SC, Kereiakes DJ, Ramee S, Greason KL, Kapadia S, Babaliaros V, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Whisenant BK, Webb JG, Mack MJ, Leon MB; PARTNER Investigators. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis. Circulation. 2016;134:130-40.
21. Athappan G, Gajulapalli RD, Tuzcu ME, Svensson LG, Kapadia SR. A systematic review on the safety of second-generation transcatheter aortic valves. EuroIntervention. 2016;11:1034-43.
22. Collas VM, Dubois C, Legrand V, Kefer J, De Bruyne B, Dens J, Rodrigus IE, Herijgers P, Bosmans JM; Belgian TAVI Registry Participants. Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry. Catheter Cardiovasc Interv. 2015;86:528-35.
23. Linke A, Wenaweser P, Gerckens U, Tamburino C, Bosmans J, Bleiziffer S, Blackman D, Schäfer U, Müller R, Sievert H, Sondergaard L, Klugmann S, Hoffmann R, Tchetche D, Colombo A, Legrand VM, Bedogni F, lePrince P, Schuler G, Mazzitelli D, Eftychiou C, Frerker C, Boekstegers P, Windecker S, Mohr FW, Woitek F, Lange R, Bauernschmitt R, Brecker S; ADVANCE study Investigators. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35:2672-84.
24. Schofer J, Colombo A, Klugmann S, Fajadet J, DeMarco F, Tchétché D, Maisano F, Bruschi G, Latib A, Bijuklic K, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Lefèvre T. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63:763-8.
25. Manoharan G, Linke A, Moellmann H, Redwood S, Frerker C, Kovac J, Walther T. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. EuroIntervention. 2016;12:768-74.
26. Hamm K, Reents W, Zacher M, Kerber S, Diegeler A, Schieffer B, Barth S. Transcatheter aortic valve implantation using the ACURATE TA and ACURATE neo valves: a four-year singlecentre experience. EuroIntervention. 2017;13:53-9.
27. Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation.2012;126:1245-55.
28. Auffret V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, Campelo-Parada F, Chiche O, Puri R, Rodés-Cabau J. Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016;68:673-84.